Traveller vaccination varicella: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Traveller vaccination | {{Traveller vaccination}} | ||
{{CMG}};{{AE}}{{USAMA}} | {{CMG}};{{AE}}{{USAMA}} | ||
==Overview== | ==Overview== |
Revision as of 18:15, 20 April 2017
Traveler Vaccination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Protection against varicella is not specific to the needs of travellers. In some countries varicella vaccine is routinely administered in childhood. Travellers missing such vaccination may be offered immunization according to national recommendations.
Disease cause
The highly contagious varicella zoster virus.
Transmission
Through droplets, aerosol and by direct and indirect contact.
Nature of the disease
Varicella is mostly a mild disease of childhood but may be more serious in adults. The disease is characterized by fever and malaise followed by an itchy, vesicular rash. Varicella may be severe or fatal in newborns and in immunocompromised individuals. Following infection varicella zoster virus remains latent in neural ganglia and may cause zoster upon subsequent reactivation.
Geographical distribution
Worldwide
Risk for travellers
As for the general population.
Vaccine
Live attenuated: often available in fixed combination with vaccines against measles, mumps and rubella.